The Cancer Killers: A “trojan horse” in the fight against cancer

The intersection of science, innovation, and human determination takes centre stage in a new SBS On Demand series, The Cancer Killers, premiering Monday, 4 November at 9:30pm. This captivating documentary delves into one of the most promising frontiers in modern healthcare: an Australian-led scientific breakthrough that could transform how we treat cancer.

A revolution in cancer treatment

The series follows scientists Dr Jennifer MacDiarmid and Dr Himanshu Brahmbhatt, whose decades-long research has led to the development of a potentially game-changing cancer treatment. Their innovation, known as the EDV – Engeneic Dream Vector, uses bacterial nano-cells to deliver chemotherapy directly into cancer cells, destroying tumours from the inside out while leaving healthy cells untouched.

Unlike conventional chemotherapy, which often causes debilitating side effects such as hair loss, nausea, and immune system damage, EDV technology eliminates toxicity and stimulates a powerful anti-tumour immune response. Early trials suggest this approach could mark a new era where cancer treatment is not only more effective but far less harmful to patients.

Science meets business: The long road to market

But as The Cancer Killers reveals, scientific discovery is only part of the story. Viewers are taken behind the scenes of the 25-year journey to commercialise this innovation, from the scientists’ humble beginnings in a government lab to building their biotech company, Engeneic.

Through intimate interviews and real-world footage, the program highlights the immense challenges of bringing a new therapy to market: navigating patents, funding hurdles, clinical trials, and the competing interests of big pharma, investors, and regulators. It is a gripping look at the tension between scientific integrity and commercial realities, and a reminder that even life-saving ideas must fight their way through the complexities of the global healthcare system.

The human story behind the science

At its core, this is also a profoundly human story. The discovery was inspired by a dying colleague’s wish for his peers to use their skills to end cancer’s suffering. That emotional catalyst sparked a lifelong mission for MacDiarmid and Brahmbhatt, one defined by perseverance, innovation, and a belief that science can and should serve humanity.

With contributions from some of the world’s leading scientists, including Ian Frazer AC, creator of the cervical cancer vaccine, and Dr Gary Gallia of Johns Hopkins University, the series captures both the hope and the high stakes of this scientific odyssey.

Why it matters

For anyone interested in the future of healthcare, The Cancer Killers offers an extraordinary window into how pioneering research can change the world. It is also a rare opportunity to witness Australian science making waves on the global stage, driven by ingenuity, resilience, and an unwavering commitment to saving lives.

Healthcare market research

At Fifth Quadrant, we explore the trends, technologies, and innovations shaping industries and improving lives. From healthcare to sustainability, our research helps organisations understand change and anticipate the future. Click here to learn more about our work in the healthcare sector or contact us today.